Report

Strong start to H2 as demand returns

COVID-19 has impacted businesses in many different ways. However for specialist high speed packaging & automation solutions provider Mpac, we think the pandemic will prove to be a long-term positive. Why?

Well the lockdowns have already started to accelerate both the reshoring of US production back from China (re supply chain disruption & US tariffs), and the adoption of the company’s expanding suite of Industry 4.0 solutions, such as remote diagnostics, virtual machine testing/commissioning & augmented reality training.

H1’20 turnover fell 20% (-32% LFL) to £36.6m YoY, due to deferred shipments, tough comparatives (record H1’19 of £45.8m) and difficulties accessing client sites. Yet equally no orders have been cancelled, whilst operating margins came in at a healthy 7.1% (adjusted EBIT £2.6m), thanks to favourable mix. Higher spare part volumes drove service revenues up +30% YoY - equivalent to 26% sales vs 17% LY. Moreover order intake declined by only -6% to £30.5m (£32.6m LY), underlining the natural resilience of their core markets: namely Healthcare (eg GSK, CooperVision, Bausch+Lomb), Food/Beverage (Ice-cream, popcorn) and pharmaceuticals.

Elsewhere, net funds closed June up £4.5m to £22.5m (or 112p/share vs £18.0m Dec’19), benefitting from tight working capital control (£3.5m inflow) and cash collection (re debtor days at pre CV19 levels). All told, providing plenty of fire-power in the event suitable M&A opportunities become available at attractive prices.
Underlying
Mpac Group

Mpac Group is focused on its Packaging Machinery business, Mpac Langen, which designs, precision engineers and manufactures packaging solutions, machinery and high specification automation, secondary packaging equipment and end-of-line robotics and at-line instrumentation and testing solutions as well as providing solutions including the design and integration of packaging systems.

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Paul Hill

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch